Switzerland· 70233002
Inluriyo 200 mg, comprimés pelliculés
A anti-estrogens product containing imlunestrantum, registered in Switzerland by Eli Lilly (Suisse) SA and dispensed under Swissmedic category B. The same ATC class is registered in 5 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Imlunestrantum is registered in 5 of 19 countries.
Countries holding a registration under ATC L02BA (anti-estrogens), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 3 of them publish a price we can compare per daily dose
Imlunestrantum · ATC L02BA
5 / 19 countries
- Czechiaprice
- Denmark
- Icelandprice
- Ireland
- Switzerlandprice
The record
At a glance
Swissmedic (Switzerland)- Active substance
- imlunestrantum
- Manufacturer
- Eli Lilly (Suisse) SA
- Country
- Switzerland (CH)
- ATC code
- L02BA
- ATC class
- Anti-estrogens
- Swissmedic category
- B
- Reimbursed
- No
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Imlunestrantum in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaINLURIYOEli Lilly Nederland B.V., Utrecht
- United StatesInluriyoEli Lilly and Company
- FinlandInluriyoEli Lilly Nederland B.V.
- FranceINLURIYO 200 mg, comprimés pelliculésELI LILLY NEDERLAND BV (PAY-BAS)
- BelgiumInluriyo 200 mgEli Lilly Nederland
- IcelandInluriyoEli Lilly Nederland B.V.*
- NetherlandsInluriyo 200 mg filmomhulde tablettenEli Lilly Nederland B.V.
- PolandInluriyoEli Lilly Nederland B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Inluriyo
- Liechtenstein · Inluriyo
- Norway · Inluriyo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a1e38ab0-5ff4-45db-9ad8-772c780990ef GET /v1/drugs/a1e38ab0-5ff4-45db-9ad8-772c780990ef?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{}See everything about imlunestrantum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.